CLINICAL USE
of Sodium Phenylbutyrate

Sodium phenylbutyrate is contributing to the global health landscape through emerging research and clinical trials.

Refer to the clinical use of sodium phenylbutyrate in research and trial studies for the treatment of disorders such as cancer, ALS, ALD, and diabetes.

Copies of clinical trials are available upon request for these indications:

  • Addiction
  • Adrenoleukodystrophy (ALD)
  • Aging
  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis (ALS)
  • Bladder dysfunction
  • Blood
  • Cancer
  • Cardiac injury
  • Cerebral ischemic injury
  • Cystic fibrosis
  • Diabetes
  • Endoplasmic reticulum stress
  • Epilepsy
  • Eye
  • Familial hypercholesterolemia
  • Spinal muscular atrophy
  • Urea cycle disorder/ornithine transcarbamylase deficiency
  • Huntington’s disease
  • Ischemic spinal cord damage
  • Kidney
  • Leucine metabolism
  • Lipoprotein receptor
  • Liver
  • Lung/abca3 defects
  • Maple syrup urine disease
  • Multiple sclerosis (MS)
  • Obesity
  • Parkinson’s disease
  • Phenylketonuria
  • Rheumatoid arthritis
  • Schizophrenia
  • Sickle cell anemia, thalassemia, and Cooley’s anemia
  • Miscellaneous research and articles
Scroll to Top